• Something wrong with this record ?

Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) Registry

D. Mekahli, KJ. van Stralen, M. Bonthuis, KJ. Jager, A. Balat, E. Benetti, N. Godefroid, VO. Edvardsson, JG. Heaf, A. Jankauskiene, L. Kerecuk, S. Marinova, F. Puteo, T. Seeman, A. Zurowska, J. Pirenne, F. Schaefer, JW. Groothoff, . ,

. 2016 ; 68 (5) : 782-788. [pub] 20160821

Language English Country United States

Document type Comparative Study, Journal Article

BACKGROUND: The choice for either kidney or combined liver-kidney transplantation in young people with kidney failure and liver fibrosis due to autosomal recessive polycystic kidney disease (ARPKD) can be challenging. We aimed to analyze the characteristics and outcomes of transplantation type in these children, adolescents, and young adults. STUDY DESIGN: Cohort study. SETTING & PARTICIPANTS: We derived data for children, adolescents, and young adults with ARPKD with either kidney or combined liver-kidney transplants for 1995 to 2012 from the ESPN/ERA-EDTA Registry, a European pediatric renal registry collecting data from 36 European countries. FACTOR: Liver transplantation. OUTCOMES & MEASUREMENTS: Transplantation and patient survival. RESULTS: 202 patients with ARPKD aged 19 years or younger underwent transplantation after a median of 0.4 (IQR, 0.0-1.4) years on dialysis therapy at a median age of 9.0 (IQR, 4.1-13.7) years. 32 (15.8%) underwent combined liver-kidney transplantation, 163 (80.7%) underwent kidney transplantation, and 7 (3.5%) were excluded because transplantation type was unknown. Age- and sex-adjusted 5-year patient survival posttransplantation was 95.5% (95% CI, 92.4%-98.8%) overall: 97.4% (95% CI, 94.9%-100.0%) for patients with kidney transplantation in contrast to 87.0% (95% CI, 75.8%-99.8%) with combined liver-kidney transplantation. The age- and sex-adjusted risk for death after combined liver-kidney transplantation was 6.7-fold (95% CI, 1.8- to 25.4-fold) greater than after kidney transplantation (P=0.005). Five-year death-censored kidney transplant survival following combined liver-kidney and kidney transplantation was similar (92.1% vs 85.9%; P=0.4). LIMITATIONS: No data for liver disease of kidney therapy recipients. CONCLUSIONS: Combined liver-kidney transplantation in ARPKD is associated with increased mortality compared to kidney transplantation in our large observational study and was not associated with improved 5-year kidney transplant survival. Long-term follow-up of both kidney and liver involvement are needed to better delineate the optimal transplantation strategy.

Children's Medical Center Landspitali The National University Hospital of Iceland Iceland

Clinic of Pediatric Nephrology and Dialysis University of Sofia Sofia Bulgaria

Department for Pediatrics Nephrology and Hypertension Medical University of Gdansk Gdansk Poland

Department of Abdominal Transplantation University Hospitals of Leuven Leuven Belgium

Department of Development and Regeneration KU Leuven Leuven Belgium

Department of Medicine Roskilde Hospital University of Copenhagen Copenhagen Denmark

Department of Pediatric Academic Medical Center Amsterdam the Netherlands

Department of Pediatric Nephrology and Rheumatology School of Medicine Gaziantep University Gaziantep Turkey

Department of Pediatric Nephrology Birmingham Children's Hospital National Health Service Foundation Trust Birmingham United Kingdom

Department of Pediatric Nephrology University Hospitals of Leuven Leuven Belgium

Department of Pediatrics Université catholique de Louvain Medical School Saint Luc Academic Hospital Brussels Belgium

ESPN ERA EDTA Registry Department of Medical informatics Academic Medical Center University of Amsterdam Amsterdam the Netherlands

Faculty of Medicine School of Health Sciences University of Iceland Reykjavik Iceland

Pediatric Nephrology and Dialysis Unit Pediatric Hospital Giovanni XXIII Bari Italy

Pediatric Nephrology Dialysis and Transplant Unit Department of Pediatrics University of Padova Italy

University Hospital Motol 2nd School of Medicine Charles University Prague Prague Czech Republic

University of Heidelberg Center for Pediatrics and Adolescent Medicine Heidelberg Germany

Vilnius University Hospital Center for Pediatrics Vilnius Lithuania

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023601
003      
CZ-PrNML
005      
20170828120004.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1053/j.ajkd.2016.06.019 $2 doi
035    __
$a (PubMed)27555106
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mekahli, Djalila $u Department of Pediatric Nephrology, University Hospitals of Leuven, Leuven, Belgium; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
245    10
$a Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) Registry / $c D. Mekahli, KJ. van Stralen, M. Bonthuis, KJ. Jager, A. Balat, E. Benetti, N. Godefroid, VO. Edvardsson, JG. Heaf, A. Jankauskiene, L. Kerecuk, S. Marinova, F. Puteo, T. Seeman, A. Zurowska, J. Pirenne, F. Schaefer, JW. Groothoff, . ,
520    9_
$a BACKGROUND: The choice for either kidney or combined liver-kidney transplantation in young people with kidney failure and liver fibrosis due to autosomal recessive polycystic kidney disease (ARPKD) can be challenging. We aimed to analyze the characteristics and outcomes of transplantation type in these children, adolescents, and young adults. STUDY DESIGN: Cohort study. SETTING & PARTICIPANTS: We derived data for children, adolescents, and young adults with ARPKD with either kidney or combined liver-kidney transplants for 1995 to 2012 from the ESPN/ERA-EDTA Registry, a European pediatric renal registry collecting data from 36 European countries. FACTOR: Liver transplantation. OUTCOMES & MEASUREMENTS: Transplantation and patient survival. RESULTS: 202 patients with ARPKD aged 19 years or younger underwent transplantation after a median of 0.4 (IQR, 0.0-1.4) years on dialysis therapy at a median age of 9.0 (IQR, 4.1-13.7) years. 32 (15.8%) underwent combined liver-kidney transplantation, 163 (80.7%) underwent kidney transplantation, and 7 (3.5%) were excluded because transplantation type was unknown. Age- and sex-adjusted 5-year patient survival posttransplantation was 95.5% (95% CI, 92.4%-98.8%) overall: 97.4% (95% CI, 94.9%-100.0%) for patients with kidney transplantation in contrast to 87.0% (95% CI, 75.8%-99.8%) with combined liver-kidney transplantation. The age- and sex-adjusted risk for death after combined liver-kidney transplantation was 6.7-fold (95% CI, 1.8- to 25.4-fold) greater than after kidney transplantation (P=0.005). Five-year death-censored kidney transplant survival following combined liver-kidney and kidney transplantation was similar (92.1% vs 85.9%; P=0.4). LIMITATIONS: No data for liver disease of kidney therapy recipients. CONCLUSIONS: Combined liver-kidney transplantation in ARPKD is associated with increased mortality compared to kidney transplantation in our large observational study and was not associated with improved 5-year kidney transplant survival. Long-term follow-up of both kidney and liver involvement are needed to better delineate the optimal transplantation strategy.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    12
$a transplantace ledvin $7 D016030
650    _2
$a jaterní cirhóza $x etiologie $x mortalita $x chirurgie $7 D008103
650    12
$a transplantace jater $7 D016031
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a polycystické ledviny autozomálně recesivní $x komplikace $x mortalita $7 D017044
650    _2
$a registrace $7 D012042
650    _2
$a renální insuficience $x etiologie $x mortalita $x chirurgie $7 D051437
650    _2
$a společnosti lékařské $7 D012955
650    _2
$a analýza přežití $7 D016019
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a van Stralen, Karlijn J $u ESPN/ERA-EDTA Registry, Department of Medical informatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
700    1_
$a Bonthuis, Marjolein $u ESPN/ERA-EDTA Registry, Department of Medical informatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: m.bonthuis@amc.uva.nl.
700    1_
$a Jager, Kitty J $u ESPN/ERA-EDTA Registry, Department of Medical informatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
700    1_
$a Balat, Ayşe $u Department of Pediatric Nephrology and Rheumatology, School of Medicine, Gaziantep University, Gaziantep, Turkey.
700    1_
$a Benetti, Elisa $u Pediatric Nephrology, Dialysis and Transplant Unit, Department of Pediatrics, University of Padova, Italy.
700    1_
$a Godefroid, Nathalie $u Department of Pediatrics, Université catholique de Louvain Medical School, Saint-Luc Academic Hospital, Brussels, Belgium.
700    1_
$a Edvardsson, Vidar O $u Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland; Children's Medical Center, Landspitali-The National University Hospital of Iceland, Iceland.
700    1_
$a Heaf, James G $u Department of Medicine, Roskilde Hospital, University of Copenhagen, Copenhagen, Denmark.
700    1_
$a Jankauskiene, Augustina $u Vilnius University Hospital, Center for Pediatrics, Vilnius, Lithuania.
700    1_
$a Kerecuk, Larissa $u Department of Pediatric Nephrology, Birmingham Children's Hospital, National Health Service Foundation Trust, Birmingham, United Kingdom.
700    1_
$a Marinova, Svetlana $u Clinic of Pediatric Nephrology and Dialysis, University of Sofia, Sofia, Bulgaria.
700    1_
$a Puteo, Flora $u Pediatric Nephrology and Dialysis Unit, Pediatric Hospital Giovanni XXIII, Bari, Italy.
700    1_
$a Seeman, Tomas $u University Hospital Motol, 2nd School of Medicine, Charles University Prague, Prague, Czech Republic.
700    1_
$a Zurowska, Aleksandra $u Department for Pediatrics, Nephrology & Hypertension, Medical University of Gdansk, Gdansk, Poland.
700    1_
$a Pirenne, Jacques $u Department of Abdominal Transplantation, University Hospitals of Leuven, Leuven, Belgium.
700    1_
$a Schaefer, Franz $u University of Heidelberg Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany.
700    1_
$a Groothoff, Jaap W $u Department of Pediatric, Academic Medical Center, Amsterdam, the Netherlands.
700    1_
$a ,
773    0_
$w MED00000258 $t American journal of kidney diseases the official journal of the National Kidney Foundation $x 1523-6838 $g Roč. 68, č. 5 (2016), s. 782-788
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27555106 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170828120550 $b ABA008
999    __
$a ok $b bmc $g 1239282 $s 984514
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 68 $c 5 $d 782-788 $e 20160821 $i 1523-6838 $m American journal of kidney diseases $n Am J Kidney Dis $x MED00000258
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...